Renovis, Inc.
Pharma company reports second quarter 2004 financial results
Published in Law and Health Weekly, September 4th, 2004
Revenue for the quarter and 6-months ended June 30, 2004, was $656,000 and $1.3 million, respectively, compared to $0 and $4.5 million for the corresponding periods in 2003. The revenue in 2004 resulted from a collaboration agreement with Genentech, which was signed at the end of 2003, while the revenue in 2003 resulted from milestone payments received from AstraZeneca plc in connection with the advancement of Cerovive (NXY-059) into Phase III clinical trials.
Research and development expenses for the second quarter and 6-month period ended June 30, 2004,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Best Practices, LLC
Drug companies approach brand security issue head on, study shows - Business Update
Altria sees $25 million gain from accounting rule - CytRx Corp.
RNAi company names Benjamin S. Levin general counsel - Drug Enforcement Administration
Government, pain groups release consensus document on prescription drug abuse - Guilford Pharmaceuticals, Inc.
GLIADEL Wafer assigned new DRG designation - Medtronic, Inc.
Medical technology company names senior VP, general counsel, corporate secretary - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
